Identifying lineage effects when controlling for population structure
  improves power in bacterial association studies by Earle, Sarah G et al.
 Page 1 
Identifying lineage effects when controlling for population structure 
improves power in bacterial association studies 
 
Sarah G Earle1*, Chieh-Hsi Wu1*, Jane Charlesworth1*, Nicole Stoesser1, N Claire Gordon1, 
Timothy M Walker1, Chris C A Spencer2, Zamin Iqbal2, David A Clifton3, Katie L Hopkins4, Neil 
Woodford4, E Grace Smith5, Nazir Ismail6, Martin J Llewelyn7, Tim E Peto1, Derrick W Crook1, 
Gil McVean2, A Sarah Walker1, Daniel J Wilson1,2 
 
Addresses: 
1 Nuffield Department of Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 
9DU, United Kingdom 
2 Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford, OX3 
7BN, United Kingdom 
3 Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, 
Oxford, United Kingdom 
4 Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, Public Health 
England, London, NW9 5EQ, United Kingdom 
5 Public Health England, West Midlands Public Health Laboratory, Heartlands Hospital, 
Birmingham, B9 5SS, United Kingdom 
6 Centre for Tuberculosis, National Institute for Communicable Diseases, Johannesburg, South 
Africa 
7 Department of Infectious Diseases and Microbiology, Royal Sussex County Hospital, Brighton, 
United Kingdom 
 
* These authors contributed equally 
Corresponding author D.J.W. Email: daniel.wilson@ndm.ox.ac.uk 
Abstract 
Bacteria pose unique challenges for genome-wide association studies (GWAS) because of strong 
structuring into distinct strains and substantial linkage disequilibrium across the genome. While 
methods developed for human studies can correct for strain structure, this risks considerable loss-
of-power because genetic differences between strains often contribute substantial phenotypic 
variability. Here we propose a new method that captures lineage-level associations even when 
locus-specific associations cannot be fine-mapped. We demonstrate its ability to detect genes and 
genetic variants underlying resistance to 17 antimicrobials in 3144 isolates from four taxonomically 
diverse clonal and recombining bacteria: Mycobacterium tuberculosis, Staphylococcus aureus, 
Escherichia coli and Klebsiella pneumoniae. Strong selection, recombination and penetrance confer 
high power to recover known antimicrobial resistance mechanisms, and reveal a candidate 
association between the outer membrane porin nmpC and cefazolin resistance in E. coli. Hence our 
method pinpoints locus-specific effects where possible, and boosts power by detecting lineage-level 
differences when fine-mapping is intractable. 
Introduction 
Mapping genetic variants underlying bacterial phenotypic variability is of great interest owing to 
the fundamental role of bacteria ecologically, industrially and in the global burden of disease1-6. 
Hospital-associated infections including Staphylococcus aureus, Escherichia coli and Klebsiella 
pneumoniae represent a serious threat to the safe provision of healthcare7-9, while the 
Mycobacterium tuberculosis pandemic remains a major global health challenge10. Treatment 
options continue to be eroded by the spread of antimicrobial resistance, with some strains resistant 
even to antimicrobials of last resort11. 
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GWAS offers new opportunities to map bacterial phenotypes through inexpensive sequencing of 
entire genomes enabling direct analysis of causal loci, and functional validation via well-developed 
molecular approaches12-27. However, bacterial populations typically exhibit genome-wide linkage 
disequilibrium (LD) and strong structuring into geographically-widespread genetic lineages or 
strains that are likely maintained by natural selection28,29. Approaches to controlling for this 
population structure have allowed for systematic phenotypic differences based on cluster 
membership20,21 or, in clonal species, phylogenetic history18,24-26. However, these and other 
approaches common in human GWAS30-32 risk masking causal variants because differences 
between strains account for large proportions of both phenotypic and genetic variability. 
 
Here we describe a new approach for controlling bacterial population structure that boosts power by 
recovering signals of lineage-level associations when associations cannot be pinpointed to 
individual loci because of strong population structure, strong LD and lack of homoplasy. We base 
our approach on linear mixed models (LMMs), which can control for close relatedness within 
samples by capturing the fine structure of populations more faithfully than other approaches33-36, 
and enjoy greater applicability than phylogenetic methods since recombination is evident in most 
bacteria37,38. Our approach offers biological insights into strain-level differences and identifies 
groups of loci that are collectively significant even when individually insignificant, without 
sacrificing power to detect locus-specific associations. 
Results 
Controlling for population structure risks widespread loss of power in bacteria 
Controlling for population structure aims to avoid spurious associations arising from (i) LD with 
genuine causal variants that are population-stratified, (ii) uncontrolled environmental variables that 
are population-stratified, and (iii) population-stratified differences in sampling31,32. In the four 
species we investigated, we observed genome-wide LD and strong population structure, with the 
first 10 principal components (PCs39) explaining 70-93% of genetic variation, compared to 27% in 
human chromosome 1 (Supplementary Fig. 1). Controlling artefacts arising from population 
structure therefore risks loss of power to detect genuine associations in this large proportion of 
population-stratified loci. 
 
For example, we investigated associations between fusidic acid resistance and the presence or 
absence of short 31bp haplotypes or kmers in S. aureus (Supplementary Fig. 2). The kmer 
approach aims to capture resistance encoded by substitutions in the core genome, the presence of 
mobile accessory genes, or both18. Kmers linked to the presence of fusC, a mobile-element-
associated resistance-conferring gene whose product prevents fusidic acid interacting with its target 
EF-G40-43, showed the strongest genome-wide association by χ2 test (p = 10-122). 
 
However, fusC-encoded resistance was observed exclusively within strains ST-1 and ST-8. Thus, 
controlling for population structure using LMM44,45 reduced significance to p = 10-39, below other 
loci (Fig. 1a, Supplementary Fig. 3). Kmers capturing resistance-conferring substitutions in fusA, 
which encodes EF-G, were propelled to greater significance because these low-frequency variants 
were unstratified, and LMM improves power in the presence of polygenic effects46 (p = 10-11 by χ2 
test, p =10-157 by LMM). However, fusA variants explain only half as much resistance as fusC 
overall. 
 
While kmers linked to fusC did not suffer outright loss of significance, as penetrance was very high, 
simulations show that for phenotypes with modest effect sizes (e.g. odds ratios of 3), controlling for 
population structure risks loss of genome-wide significance at 59%, 75%, 99% and 99% of high-
frequency causal variants in M. tuberculosis (n = 1573), S. aureus (n = 992), E. coli (n = 241) and 
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K. pneumoniae (n = 176) simulations respectively, with power loss greatest when sample size is 
low and the number of variants is high (Fig. 2a, Supplementary Fig. 4a). 
Detecting lineage- versus locus-specific associations 
Methods to limit loss of power such as leave-one-chromosome-out46,47 are impractical in bacteria, 
which typically have one chromosome. Instead we developed a method to recover information 
discarded when controlling for population structure. In cases where population stratification reduces 
power to detect locus-specific associations, our method infers lineage-specific associations, similar 
to a phylogenetic regression48-50, without sacrificing power to detect locus-specific associations 
when able to do so. 
 
We observed that leading PCs tend to correspond to major lineages in bacterial genealogies (or 
clonal frames51-53) despite substantial differences in recombination rates (Fig. 1b, Supplementary 
Fig. 5), reflecting an underlying relationship between genealogical history and PC analysis54. PCs 
are commonly used to control for population structure by including leading PCs as fixed effects in a 
regression39. Therefore regression coefficients estimated for PCs could be interpreted as capturing 
lineage-level phenotypic differences, and each PC tested for an effect on the phenotype. Since PCs 
are guaranteed to be uncorrelated, defining lineages in terms of PCs, rather than as phylogenetic 
branches or genetic clusters, minimizes loss-of-power to detect lineage-level associations caused by 
correlations between lineages. 
 
To identify lineage effects we exploited a connection between PCs and LMMs. In an LMM, every 
locus is included as a random effect in a regression. This is equivalent to including every PC in the 
regression as a random effect55. Therefore we decomposed the random effects estimated by the 
LMM to obtain coefficients and standard errors for every PC (see Methods). We then employed a 
Wald test56 to assess the significance of the association between each lineage and the phenotype. 
 
Our method, implemented in the R package bugwas, revealed strong signals of association between 
fusidic acid resistance and lineages including PC-6 and PC-9 (p = 10-70), comparable in significance 
to the low-frequency variants at fusA (Fig. 1c, Supplementary Fig. 6). We next reassessed locus-
specific effects by assigning variants to lineages according to the PC to which they were most 
correlated, and comparing the significance of variants within lineages. This showed that fusC and 
variants in LD with fusC accounted for the strongest signals within PC-6 and PC-9 (p = 10-34 
and 10-45 respectively) (Fig. 1d), with the strongest locus-specific associations localized to a 20kb 
region containing the staphylococcal cassette chromosome (SCC), the most significant hit mapping 
to the gene adjacent to fusC. Thus identifying loci contributing to the most significant lineages 
provides an alternative to prioritizing variants for follow-up based solely on locus-specific 
significance. 
 
In simulations, our method was able to recover signals of lineage-level associations in cases where 
significance at individual loci was lost by controlling for population structure, increasing power 2.5- 
(M. tuberculosis) to 22.0-fold (E. coli) (Fig. 2a, Supplementary Fig. 4a). LMM reduced the 
number of falsely detected SNPs by 30- (K. pneumoniae) to 3600-fold (S. aureus). However, fine-
mapping of causal variants to specific chromosomal regions frequently suffered from genome-wide 
LD because LD is not generally organized into physically linked blocks along the chromosome 
(Fig. 2b, Supplementary Fig. 4b), underlining the importance of recovering power by interpreting 
lineage effects. 
 
We noted a trade-off to interpreting lineage effects because they are susceptible to confounding 
with population-stratified differences in environment or sampling (Supplementary Fig. 7). 
Therefore, non-random associations between lineages and uncontrolled variables that influence 
phenotype risks false detection of lineage-level differences. 
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Multi-drug resistance and multisite resistance mechanisms influence signals of 
association 
Confronted with strong population structure and genome-wide LD in bacteria, we wished to test 
empirically the ability of GWAS to pinpoint genuine causal variants more generally. Therefore we 
conducted 26 GWAS for resistance to 17 antimicrobials in 3144 isolates across the major pathogens 
M. tuberculosis57, S. aureus58, E. coli and K. pneumoniae59 (Supplementary Fig. 8). 
 
We supplemented the kmer approach by surveying variation in SNPs and gene presence or absence. 
We imputed missing SNP calls by reconstructing the clonal frame51,53 followed by ancestral state 
reconstruction61, an approach that generally outperformed imputation using Beagle60 
(Supplementary Table 1). 
 
Correlated phenotypes caused by the presence of multi-drug resistant isolates led to significant 
results in unexpected loci or regions in some analyses. A combination of first-line drug regimens 
contributes to multi-drug resistance co-occurrence in M. tuberculosis, which led to spurious 
associations as the top hit before controlling for population structure between ethambutol and 
pyrazinamide resistance and SNPs in rifampicin resistance-conferring rpoB. Even after controlling 
for population structure, these associations remained genome-wide significant at p = 10-45 and 
p = 10-54. 
 
Antimicrobial resistance has arisen over 20 times per drug in the M. tuberculosis tree, through 
frequent convergent evolution (Supplementary Fig. 4c, Supplementary Fig. 8). Within a single 
gene, such as rpoB, there are multiple targets for selection. Both SNP and kmer-based approaches 
correctly identified variants in known resistance-causing codons, but greater significance was 
attained in the latter since the targets for selection were typically within 31bp (Supplementary Fig. 
9a). In these cases, absence of the wild type allele was found to confer resistance, with power 
gained by pooling over the alternative mutant alleles. 
Strong selection and recombination assist fine-mapping of antibiotic resistance 
determinants 
For each drug and species, we evaluated whether the most significant hit identified by GWAS 
matched a known causal variant57-59 (Supplementary Table 2). By this measure, the performance 
of GWAS across species was very good, identifying genuine causal loci or regions in physical 
linkage with those loci for antimicrobial resistance in 25/26 cases for the SNP and gene approach 
and the kmer approach after controlling for population structure (Table 1, Supplementary Table 
3). Particularly for accessory genes such as β-lactamases, mobile element-associated regions of LD 
were often detected along with the causal locus (Supplementary Figure 9b). 
 
Genuine resistance-conferring variants were detected in all but one study, demonstrating that the 
high accuracy attained in predicting antimicrobial resistance phenotypes from genotypes known 
from the literature58,62 is mirrored by good power to map the genotypes that confer antimicrobial 
resistance phenotypes using GWAS. However, these results also reflect extraordinary selection 
pressures exerted by antimicrobials. High homoplasy at resistance-conferring loci caused by repeat 
mutation and recombination break down LD, assisting mapping (Fig. 2c, Supplementary Fig. 4c). 
 
For one drug, cefazolin, in E. coli, we identified variation in the presence of an unexpected gene as 
the most strongly associated with resistance, nmpC (p = 10-12.4). This gene encodes an outer 
membrane porin over-represented in susceptible individuals. Permeability in the Salmonella 
typhimurium homolog mediates resistance to other cephalosporin beta-lactams63, making this a 
strong candidate for a novel resistance-conferring mechanism discovered in E. coli. 
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Conclusions 
Population structure presents the greatest challenge for GWAS in bacteria, because of the inherent 
trade-off between power to detect genuine associations of population-stratified variants and 
robustness to unmeasured, population-stratified confounders. By introducing a test for lineage-
specific associations, we allow these signals to be recovered even in the absence of homoplasy, 
while acknowledging the increased risk of confounding. Detecting lineage effects is valuable 
because characterizing phenotypic variability in terms of strain-level differences is helpful for 
biological understanding and it permits the prediction of traits, including clinically actionable 
phenotypes, from strain designation. 
 
Identifying loci that contribute to the most significant lineage-level associations offers flexibility in 
the interpretation of bacterial GWAS, where it will often be difficult to pinpoint significance to 
individual locus effects, and where LD can make the fine-mapping of causal loci a genome-wide 
problem. Loci can be prioritized for follow-up by identifying groups of lineage-associated variants 
that collectively show a strong signal of phenotypic association, but which cannot be distinguished 
statistically. This strategy provides an alternative to prioritizing variants based solely on locus-
specific significance, but it carries risks, because lineage-associated effects are more susceptible to 
confounding with population-stratified differences in environment or sampling. This trade-off 
between power and robustness underlines the importance of functional validation for bacterial 
GWAS going forward. 
Methods 
 
Linear mixed model. In the linear mixed model44-47 (LMM), the phenotype is modelled as 
depending on the fixed effects of covariates including an intercept, the "foreground" fixed effect of 
the locus whose individual contribution is to be tested, the "background" random effects of all the 
loci whose cumulative contribution to phenotypic variability we will decompose into lineage-level 
effects, and the random effect of the environment: 
phenotype = covariates + foreground locus + background loci + environment 
Formally, 
yi = Wi1α1 + … + Wicαc + Xilβl + Xi1γ1 + … + XiLγL + εi, 
where there are n individuals, c covariates, L loci, l is the foreground locus, yi is the phenotype in 
individual i, Wij is covariate j in individual i, αj is the effect of covariate j, Xij is the genotype of 
locus j in individual i, βl is the foreground effect of locus l, γj is the background effect of locus j and 
εi is the effect of the environment (or error) on individual i. Biallelic genotypes are numerically 
encoded as −fj (common allele) or 1−fj (rare allele), where fj is the frequency of the rare allele at 
locus j. This convention ensures the mean value of Xij over individuals i is zero for any locus j. 
Since triallelic and tetrallelic loci are rare, we use only biallelic loci to model background effects. 
When the foreground locus is triallelic (K = 3) or tetrallelic (K = 4), the genotype in individual i is 
encoded as a vector indicating the presence (1) or absence (0) of the first (K−1) alleles and βl 
becomes a vector of length (K−1). 
 
Treating the background effects of the loci as random effects means the precise values of the 
coefficients γj are averaged over. The γjs are assumed to follow independent normal distributions 
with common mean 0 and variance λτ−1 to be estimated. Since most loci are expected to have little 
or no effect on a particular phenotype, this tends to constrain the magnitude of the background 
effect sizes to be small. The environmental effects are also treated as random effects assumed to 
follow independent normal distributions with mean 0 and variance τ−1. The model can be rewritten 
in matrix form as 
y = W α + Xl βl + u + ε 
with 
u = X1 γ1 + … + XL γL 
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u ~ MVNn(0, λ τ−1 K) 
ε ~ MVNn(0, τ−1 In) 
where u represents the cumulative background effects of the loci, MVN denotes the multivariate 
normal distribution, In is an n × n identity matrix and K is an n × n relatedness matrix defined as 
K = X X′, which captures the genetic covariance between individuals. 
 
Testing for locus effects. To assess the significance of the effect of an individual locus l on the 
phenotype, controlling for population structure and background genetic effects, the parameters of 
the linear mixed model α1…αc, βl, λ and τ were estimated by maximum likelihood and a likelihood 
ratio test with (K−1) degrees of freedom was performed against the null hypothesis that βl = 0 using 
the software GEMMA45. 
 
Testing for lineage effects. Since controlling for population structure drastically reduces power at 
population-stratified variants, and since a large proportion of variants are typically population-
stratified in bacteria, we recovered information from the LMM regarding lineage-level differences 
in phenotype. 
 
We defined lineages using principal components (PCs) because we observed that PCs tend to trace 
paths through the clonal frame genealogy corresponding to recognizable lineages and because PCs 
are mutually uncorrelated, minimizing loss-of-power to detect differences between lineages due to 
correlations. PCs were computed based on biallelic SNPs using the R function prcomp(), producing 
an L by n loading matrix D and an n by n score matrix T where T = X D. Dij records the 
contribution of biallelic SNP i to the definition of PC j while Tij represents the projection of 
individual i on to PC j. 
 
Point estimates and standard errors for the background locus effects are usually overlooked because 
the assumed normal distribution with common mean 0 and variance λτ−1 tends to cause them to be 
small in magnitude and not significantly different from zero. However, cumulatively the 
background locus effects can capture systematic phenotypic differences between lineages. 
Therefore we recovered the post-data distribution (equivalent to an empirical Bayes posterior 
distribution) of the background locus random effects, γ, from the LMM, and reinterpreted it in terms 
of lineage-level differences in phenotype. 
 
Empirically, we found that the post-data distribution of the background random effects was 
generally insensitive to the identity of the foreground locus and comparable under the null 
hypothesis (βl = 0). Therefore, we calculated the mean and variance-covariance matrix of the 
multivariate normal post-data distribution of γ in the LMM null model. These are equivalent to 
those of a ridge regression64, and were computed as 
μ = (X′X + 1/λ IL)-1 X′y and Σ = (τ X′X + 1/λ IL)-1 
respectively. Both λ and τ were estimated by GEMMA under the LMM null model. 
 
Using the inverse transformation of the biallelic variants from PCA, X = T D−1, the background 
random effects can be rewritten in terms of the contribution of the n PCs 
u = X1 γ1 + … + XL γL 
= X γ = T D−1 γ = T g 
=  T1 g1 + … + Tn gn 
where g = D−1 γ, gj being the background effect of PC j on the phenotype. We therefore computed 
the mean and variance of the post-data distribution of g as m = D−1μ and S = D−1ΣD respectively 
using the affine transformation for a multivariate normal distribution. To test the null hypothesis of 
no background effect of PC j (i.e. gj = 0) we employed a Wald test with test statistic wj = mj2/Sjj, 
which we compared against a chi-squared distribution with one degree of freedom to obtain a p-
value. 
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While we identified and tested for lineage effects in the LMM setting, lineage effects could also be 
identified and tested for by interpreting the coefficients of leading PCs or genetic cluster 
membership included as fixed effects in a regression, both of which represent alternative methods 
for controlling for population structure. 
 
Identifying non genome-wide PCs. Some PCs capture variation localized to particular areas of the 
genome. We identified non genome-wide PCs by testing for spatial heterogeneity of the loading 
matrix W for biallelic SNPs across the genome. SNPs were grouped into 20 contiguous bins 
(indexed by j) of nearly equal sizes Nj and the mean Oij and variance Vij in the absolute value of the 
SNP loadings for PC i in bin j were calculated, along with the mean absolute value Ei of the SNP 
loadings for PC i across all SNPs. The null hypothesis of no heterogeneity was assessed by 
comparing the test statistic χi2 = Σj (Oij – Ei)2/(Vij/Nj) to a chi-squared distribution with degrees of 
freedom equal to the number of bins minus one to obtain a p-value. 
 
Antimicrobial resistance testing, genome sequencing and SNP calling. We investigated 241 E. 
coli and 176 K. pneumoniae UK clinical isolates newly reported here, together with 992 S. aureus 
and 1735 M. tuberculosis isolates reported previously57,58. All isolates were tested for resistance to 
multiple antimicrobials based on routine clinical laboratory protocols and DNA was extracted and 
sequenced on Illumina platforms as previously described57-59. We called SNPs using standard 
methods65,66, employing Stampy67 to map reads to reference strains CFT073 (genbank accession 
AE014075.1), MGH 78578 (CP000647.1), H37Rv (NC_000962.2) and MRSA252 (BX571856.1) 
for Escherichia coli, Klebsiella pneumoniae, Mycobacterium tuberculosis and Staphylococcus 
aureus respectively. All genomes were deposited in NCBI and EBI short read archives under 
project accession numbers PRJNA306133 (E. coli and K. pneumoniae), PRJ-282721, PRJEB2221, 
PRJEB5162 (M. tuberculosis), PRJEB5225 and PRJEB5261(S. aureus). Individual accession 
numbers and antimicrobial resistance phenotypes are detailed in Supplementary Data 1. The 
distributions of biallelic SNP frequencies are provided in Supplementary Table 4. 
 
Defining the pan-genome. In order to investigate gene presence or absence we created a pan-
genome for each set of isolates. To obtain whole genome assemblies, reads were de novo assembled 
using Velvet68. We annotated open reading frames on the de novo assemblies for each isolate. We 
then used the Bayesian gene-finding program Prodigal69 to identify a set of protein sequences for 
each de novo assembly. These annotated protein sequences were clustered using CD-hit70 with a 
clustering threshold of 70% identity across 70% of the longer sequence. We converted the output of 
CD-hit into a matrix of binary genotypes denoting presence or absence of each gene cluster in each 
genome (Supplementary Fig. 2). 
 
Kmer counting. Some diversity such as indels and repeats is difficult to capture using standard 
variant calling tools. To capture non-SNP variation, we pursued a kmer or word-based approach18 
in which all unique 31 base haplotypes were counted from the sequencing reads using dsk71 
following adaptor trimming and removal of duplicates and low quality reads using Trimmomatic72. 
If a kmer was counted five or more times in an isolate, then it was counted as present, and if not it 
was treated as absent (Supplementary Fig. 2). This produced a deduplicated set of variably present 
kmers across the dataset, with the presence or absence of each determined per isolate. The total 
number of SNPs, kmers and gene clusters per species can be found in Supplementary Table 5. 
 
Phylogenetic inference. Maximum likelihood phylogenies were estimated for visualization and 
SNP imputation purposes using RAxML version 7.7.6 73, with a GTR model and no rate 
heterogeneity, using alignments from the mapped data based on biallelic sites, with non-biallelic 
sites being set to the reference. 
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SNP imputation. Since Illumina sequencing is inherently more error-prone than Sanger 
sequencing, strict filtering is required for reliable mapping-based SNP calling, contributing to a 
small but appreciable frequency of uncalled bases in the genome due to ambiguity or deletion. 
Restricting analysis to sites called in all genomes is undesirable, while ignoring uncalled sites by 
removing individuals with missing data at individual sites generates p-values that cannot be validly 
compared between sites because they are calculated using data from differing sets of isolates. 
 
SNP imputation is therefore generally considered necessary for GWAS60. We imputed missing base 
calls using two approaches, ClonalFrameML53 and Beagle60. Imputation using ClonalFrameML53 
involves jointly reconstructing ancestral states and missing base calls by maximum likelihood 
utilizing the phylogeny reconstructed earlier61. To use Beagle the mapped data was coded as 
haploid (one column per individual), and input as phased data60,74. 
 
Testing imputation accuracy. To simulate data for testing imputation accuracy, 100 sequences 
were randomly sampled from each GWAS dataset across the phylogeny. Maximum likelihood 
phylogenies were estimated for the 100 sequences of each species using RAxML73 as above. Any 
columns in the alignment corresponding to ambiguous bases in the reference genome were 
excluded. One round of imputation was performed using ClonalFrameML to produce complete 
datasets with no ambiguous bases (Ns) that were then treated as the truth for the purpose of testing. 
The empirical distributions of Ns per site in the datasets of 100 sequences were determined, and 
these were sampled with replacement to reintroduce Ns to the variable sites in 100 simulated 
datasets. These sequences were then imputed again using ClonalFrameML and Beagle. Accuracy 
was summarized per site as a function of the frequency of Ns per site and the minor allele 
frequency. Overall ClonalFrameML was more accurate than Beagle, thus ClonalFrameML was 
used for all GWAS analyses (Supplementary Table 1). 
 
Calculating association statistics before controlling population structure. We wished to 
compare the significance of associations before and after controlling for population structure. For 
the SNP and gene presence or absence data, an association between each SNP or gene and the 
phenotype was tested by logistic regression implemented in R. For the kmer analyses, an 
association between the presence or absence of each kmer was tested using a χ2 test implemented in 
C++. For each variant a p-value was computed. 
 
Correction for multiple testing. Multiple testing was accounted for by applying a Bonferroni 
correction75; the individual locus effect of a variant (SNP, gene or kmer) was considered significant 
if its p-value was smaller than α/np where we took α = 0.05 to be the genome-wide false positive 
rate and np to be the number of SNPs and genes, or kmers, with unique phylogenetic patterns, i.e. 
unique partitions of individuals according to allele membership. Since the phenotypic contribution 
of multiple variants with identical phylogenetic patterns cannot be disentangled statistically, we 
found that pooling such variants improved power by demanding a less conservative Bonferroni 
correction than correcting for the total number of variants (Supplementary Fig. 10). 
 
The genome-wide -log10 p-value threshold for SNPs and genes (or kmers) was 6.1 (7.3) for S. 
aureus ciprofloxacin, erythromycin, fusidic acid, gentamicin, penicillin, methicillin, tetracycline 
and rifampicin, 5.9 (6.7) for S. aureus trimethoprim, 6.5 (7.3) for all antimicrobials tested for E. 
coli, 6.6 (7.3) for all antimicrobials tested for K. pneumoniae, and 5.0 (7.6) for all antimicrobials 
tested for M. tuberculosis. We also accounted for multiple testing of lineage effects by applying a 
Bonferroni correction for the number of PCs, which equals the sample size n. 
 
Running GEMMA. For the analyses of SNPs, genes and kmers, we computed the relatedness 
matrix K from biallelic SNPs only. We tested for foreground effects at all biallelic, triallelic and 
tetrallelic SNPs, genes and kmers. GEMMA was run using a minor allele frequency of 0 to include 
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all SNPs. GEMMA was modified to output the ML log-likelihood under the null and alternative, 
and -log10 p-values were calculated using R. 
 
To perform LMM on tri- and tetra-allelic SNPs, each SNP was encoded as K–1 binary columns 
corresponding to the first K–1 alleles. For each column, an individual was encoded 1 if it contained 
that allele and 0 otherwise. The first column was input as the genotype, and the others as covariates 
into GEMMA. The log likelihood of the null from the biallelic SNPs along with the log likelihood 
under the alternative for each of the SNPs were used to calculate the p-value per SNP. 
 
Due to the large number of kmers present within each dataset, it was not feasible to run LMM on all 
kmers. Thus we applied the LMM to the top 200,000 most significant kmers from the logistic 
regression, plus 200,000 randomly selected kmers of those remaining. The randomly selected kmers 
were used to indicate whether some were becoming relatively more significant than the top 
200,000, providing a warning in case large numbers of kmers became significant only after 
controlling for population structure. 
 
Variant annotation. SNPs were annotated in R using the reference fasta and genbank files to 
determine SNP type (synonymous, non-synonymous, nonsense, read-through, intergenic), the 
codon and codon position, reference and non-reference amino acid, gene name and gene product.  
 
Unlike the SNP approach where we can easily refer to the reference genome to find what gene the 
SNP is in and the effect that it may have, annotation of the kmers is more difficult. We used 
BLAST76 to identify the kmers in databases of annotated sequences. Each kmer was first annotated 
against a BLAST database created of all refseq genomes of the relevant genus on NCBI. This 
enabled automatic annotation of all kmers that gave a sufficiently small e-value against the genus 
specific database. All kmers were also searched against the whole nucleotide NCBI database, firstly 
to compare and confirm the matches made against the first database, and secondly to annotate the 
kmers that did not match to anything in the within-genus database. Finally, when the resistance 
determining mechanism was a SNP, the top 10000 kmers were mapped to a relevant reference 
genome using Bowtie277. This was used to determine whether the most significant kmers covered 
the position of the resistance causing SNP or whether they were found elsewhere in the gene. 
 
Genes were annotated for each CD-hit gene cluster by performing BLAST76 searches of each 
cluster sequence against a database of curated protein sequences downloaded from UNIPROT78. 
 
Testing power by simulating phenotypes. To assess the performance of the method for 
controlling population structure, we performed 100 simulations per species. In each simulation, a 
biallelic SNP was randomly chosen among those SNPs with minor allele frequency above 20% to 
be the causal SNP. Binary phenotypes (case or control) were then simulated for each genome with 
case probabilities of 0.25 and 0.5 respectively in individuals with the common and rare allele at the 
causal SNP (an odds ratio of 3). For each simulated dataset, we tested for locus effects at every 
biallelic SNP and lineage effects at every PC, as described above. Power to detect locus effects was 
defined as the proportion of simulations in which the causal SNP was found to have a significant 
locus effect. This was compared to a theoretically optimum power computed as the proportion of 
simulations in which the causal SNP was found to have a significant locus effect when population 
structure and multiple testing were not controlled for. Power to detect lineage effects was computed 
as the proportion of simulations in which the PC most strongly correlated to the causal SNP was 
found to have a significant lineage effect. We defined fine mapping precision as the distance 
spanned by SNPs within two log-likelihoods of the most significant SNP in the test for locus 
effects, in those simulations in which the causal locus was genome-wide significant. We calculated 
the number of homoplasies per SNP by counting the number of branches in the phylogeny affected 
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by a substitution based on the ClonalFrameML ancestral state reconstruction, and subtracting the 
minimum number of substitutions (K–1). 
 
Software. We have created an R package bugwas implementing our method for controlling 
population structure and an end-to-end GWAS pipeline using R, Python and C++. Both can be 
downloaded from www.danielwilson.me.uk/virulogenomics.html. 
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Figure Legends 
Figure 1. Controlling for population structure in bacterial GWAS for fusidic acid resistance in S. 
aureus. (a) Effect of controlling for population structure using LMM on significance of the 
presence or absence of 31bp kmers. The 200,000 most-significant kmers prior to control for 
population structure and a random 200,000 are plotted. Each kmer is colour-coded according to the 
PC to which it is most strongly correlated, grey if it is not most strongly correlated to one of the 20 
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most significant PCs. (b) PCs correspond to lineages in the clonal genealogy. Branches are colour-
coded by one of the 20 most significant PCs to which they are most correlated. Individual genomes 
are colour-coded with black or grey lines to indicate fusidic acid resistance and susceptibility 
respectively. The circle passing through the line is colour-coded to indicate the phenotype predicted 
by the LMM. (c) Wald tests of significance of lineage-specific associations. Some PCs, e.g. PC 9, 
are hashed to indicate that no branch in the clonal genealogy was most strongly correlated with it. 
Asterisks above the bars, e.g. PC 25, indicate evidence for lineages associated with particular 
genomic regions. (d) Manhattan plot showing significance (-log10 p-values) of unique variants after 
controlling for population structure, with variants clustered by PC. The horizontal ordering is 
randomised. This allows identification of the variants corresponding to the most significant lineage-
specific associations. 
 
Figure 2. Power, false positives, fine mapping and homoplasy in S. aureus. Simulation results. (a) 
Controlling for population structure and multiple testing lead to a drastic reduction in power to 
detect locus effects, compared to the theoretical optimum power for a single locus. The Wald test 
improves power several-fold by detecting lineage-specific effects. (b) Top: Mean number of false 
positive SNPs and patterns is drastically reduced by controlling population structure with LMM. 
Bottom: Fine mapping precision is very coarse owing to genome-wide LD. Interpreting lineage 
effects is useful when the locus-specific signal cannot be fine-mapped. (c) The number of times 
common SNPs (MAF>20%) and antibiotic resistance phenotypes have emerged on the phylogeny. 
(d) When homoplasy is high, power to detect locus effects is much improved, explaining the good 
power to map antibiotic resistance phenotypes. In the simulations, causal loci were selected at 
random from high frequency SNPs (MAF>20%) in the n = 992 isolates and phenotypes simulated 
per genome with case probabilities of 0.25 and 0.5 for the common and rare alleles respectively 
(odds ratio of 3). Genome wide significance (to detect locus effects) was based on a Bonferroni-
corrected p-value threshold of α, equal to 0.05 divided by the number of SNP patterns. 
 
 


Table 1 Number of resistant and sensitive isolates by species and antibiotics, known mechanisms of resistance and main results. The rank of the most significant result for an expected 
causal mechanism for each GWAS is reported, plus in brackets the gene that was most significant when it was not causal. Where more than one gene or mechanism causes resistance, the 
variant we found was underlined, or referred to by a and b. R = Resistant. S = Sensitive. HP = Hypothetical Protein, tnp = transposase. PMQR = Plasmid Mediated Quinoline Resistance. 
See Supplementary Tables 3-6 for more detail.  
 
Resistance determined by gene presence Most significant variant was the expected mechanism
   Resistance determined by SNPs    Most significant variant was in physical linkage (PL) with the expected 
             Mechanism
   Resistance determined by gene presence or SNPs or both    Most significant variant was not the expected mechanism or in PL with the 
             expected mechanism
 
 Antibiotic # R # S Resistance mechanism SNP / gene rank SNP / gene LMM rank Kmer rank Kmer LMM rank 
E. coli        
 Ampicillin  189 52 β-lactamase genes 
blaTEM 
1 1 6 (tnp) 
6 
(tnp) 
 Cefazolin 139 102 β-lactamase genes 
blaCTX-M 
2 
(nmpC) 
3 
(nmpC) 
121710 
(nmpC) 
3690 
(nmpC) 
 Cefuroxime 81 160 β-lactamase genes 
blaCTX-M 1 1 
1598 
(162-192 upstream 
blaCMY-2) 
470 
(162-192 upstream 
blaCMY-2) 
 Ceftriaxone 55 186 β-lactamase genes 
blaCTX-M 
1 1 1403 (tnp) 
470 
(tnp) 
 Ciprofloxacin  91 150 SNPs in gyrAa, gyrB, parCb or 
parE or presence of PMQR 1
b 1b 1b 1a 
 Gentamicin  48 193 aac (aac(3)-II),  ant, aph or rRNA 
methylase 1 1 1 1 
 Tobramycin 67 174 aac (aac(3)-II),  ant or rRNA 
methylase 1 1 1 1 
K. pneumoniae        
 Cefazolin 53 123 β-lactamase genes  
blaCTX-M 
1 + HP + wbuC 1 762 (tnp) 
837 
(tnp) 
 Cefuroxime 46 130 β-lactamase genes  
blaCTX-M 
1 + HP  + wbuC 1+ HP + wbuC  
762 
(tnp) 
1480 
(tnp) 
 Ceftriaxone 35 141 β-lactamase genes 
blaCTX-M 1 + HP + wbuC 1 + HP + wbuC 
771 
(tnp) 
812 
(tnp) 
 Ciprofloxacin 34 142 SNPs in gyrA, gyrB, parC or parE 
or presence of PMQR (qnr-B1a, 
qnr-B19b) 
2a 
(tnp) 
2a 
(tnp) 
1853b 
(tnp) 
4427b  
(tnp) 
 Gentamicin  31 145 aac (acc(3)-II),  ant, aph or rRNA 
methylase 1 1 1 
79 
(tmrB_2) 
 Tobramycin 36 140 aac (acc(3)-II),  ant  or rRNA 
methylase 1 1 1 1 
M. tuberculosis        
 Ethambutol 41 1589 embB 2 
(rpoB) 1 1 1 
 Isoniazid 239 1470 katG, fabG1 1 1 1 1 
 Pyrazinamide 45 1662 pncA 142 
(rpoB) 1 
126 
(rpoB) 1  
 Rifampin 86 1487 rpoB 1 1 1 1  
S. aureus        
 Ciprofloxacin 242 750 grlA or gyrA 1 1 1 1 
 Erythromycin 216 776 ermA, ermC, ermT or msrA 1 1 1 1 
 Fusidic acid 84 908 SNPs in fusAa or presence of fusB 
or fusCb 
4b 
(SAS0037) 1
a 75
b 
(SAS0040) 1
a 
 Gentamicin 11 981 aacA/aphD 1 + GNAT 
acetyltransferase 
1 + GNAT 
acetyltransferase 
1 + 415 bases 
upstream to 100 
bases downstream 
1 + 415 bases 
upstream to 100 bases 
downstream 
 Penicillin 824 168 blaZ 1 1  2 (blaI) 
2 
(blaI) 
 Methicillin 216 776 mecA 1 1 + mecR1 1 + SCCmec genes 1 + SCCmec genes 
 Tetracycline 46 946 tetK, tetL or tetM 2 
(repC) 
2 
(repC) 1 + plasmid genes 1 + plasmid genes 
 Trimethoprim 15 308 SNPs in dfrB, presence of dfrG or 
dfrA  1 1 1 1 
 Rifampicin 8 984 rpoB 1 1 1 1 
